Open access · CC-BY
via OpenAlex
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Paolo Calabresi, Alessandro Mechelli, Giuseppina Natale, Laura A. Volpicelli‐Daley, Giulia Di Lazzaro, Veronica Ghiglieri
Cell Death and Disease · 2023 · ▲ 820 citations
Abstract
Although the discovery of the critical role of α-synuclein (α-syn) in the pathogenesis of Parkinson's disease (PD) is now twenty-five years old, it still represents a milestone in PD research. Abnormal forms of α-syn trigger selective and progressive neuronal death through mitochondrial impairment, lysosomal dysfunction, and alteration of calcium homeostasis not only in PD but also in other α-syn-related neurodegenerative disorders such as dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, and REM sleep behavior disorder. Furthermore, α-syn-dependent early synaptic and plastic alterations and the underlying mechanisms preceding overt neurodegeneration have attracted great interest. In particular, the presence of early inflammation in experimental models and PD patients, occurring before deposition and spreading of α-syn, suggests a mechanistic link between inflammation and synaptic dysfunction. The knowledge of these early mechanisms is of seminal importance to support the research on reliable biomarkers to precociously identify the disease and possible disease-modifying therapies targeting α-syn. In this review, we will discuss these critical issues, providing a state of the art of the role of this protein in early PD and other synucleinopathies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41419-023-05672-9
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Calabresi, P., Mechelli, A., Natale, G., Volpicelli‐Daley, L.A., Lazzaro, G.D., & Ghiglieri, V. (2023). Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. <em>Cell Death and Disease</em>. https://doi.org/10.1038/s41419-023-05672-9
Vancouver
Calabresi P, Mechelli A, Natale G, Volpicelli‐Daley LA, Lazzaro GD, Ghiglieri V. Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death and Disease. 2023. doi:10.1038/s41419-023-05672-9.
BibTeX
@article{paolo2023Alphas,
title = {Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction},
author = {Paolo Calabresi and Alessandro Mechelli and Giuseppina Natale and Laura A. Volpicelli‐Daley and Giulia Di Lazzaro and Veronica Ghiglieri},
journal = {Cell Death and Disease},
year = {2023},
doi = {10.1038/s41419-023-05672-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Movement disorders : official journal of the Movement Disorder Society 2026
Citation only
Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids.
Ageing Research Reviews 2020
Preprint · OA
Circadian and sleep dysfunction in Alzheimer’s disease
Oxidative Medicine and Cellular Longevity 2012
Open access · CC-BY
Antioxidant Therapies for Alzheimer's Disease
Current Neurovascular Research 2017
Preprint · OA
Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer
Science 2020
Preprint · OA
Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases
Cold Spring Harbor Perspectives in Medicine 2012
Preprint · OA